Stage IIIA Hepatocellular Carcinoma AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00062 | Albumin human | 1 | Suspended | 1 |
| DB11595 | Atezolizumab | 1 | Suspended | 1 |
| DB08875 | Cabozantinib | 1 | Suspended | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Suspended | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB00020 | Sargramostim | 1 | Recruiting | 1 |
| DB11771 | Tremelimumab | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 / 2 | Suspended | 1 |
| DB14986 | Linrodostat | 1 / 2 | Terminated | 1 |
| DB09035 | Nivolumab | 1 / 2 | Suspended | 1 |
| DB09035 | Nivolumab | 1 / 2 | Terminated | 1 |
| DB11595 | Atezolizumab | 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Recruiting | 2 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Recruiting | 2 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB11759 | Pevonedistat | 2 | Active Not Recruiting | 1 |
| DB08896 | Regorafenib | 2 | Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Active Not Recruiting | 1 |
| DB11771 | Tremelimumab | 2 | Recruiting | 1 |